{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:40:45Z","timestamp":1782452445216,"version":"3.54.5"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["1-K08-MH117351-01"],"award-info":[{"award-number":["1-K08-MH117351-01"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH131720-01"],"award-info":[{"award-number":["R01MH131720-01"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["1R01MH104459-01"],"award-info":[{"award-number":["1R01MH104459-01"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["1 R01 MH116657-01A1"],"award-info":[{"award-number":["1 R01 MH116657-01A1"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32 DA 22975-15"],"award-info":[{"award-number":["T32 DA 22975-15"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR001862"],"award-info":[{"award-number":["KL2TR001862"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41386-025-02296-9","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T03:03:54Z","timestamp":1766113434000},"page":"799-806","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In vivo evidence for metabotropic glutamate receptor 5 dysregulation in chronic pain"],"prefix":"10.1038","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7297-710X","authenticated-orcid":false,"given":"Margaret T.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9276-6714","authenticated-orcid":false,"given":"Nicole","family":"DellaGioia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Boster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9575-0183","authenticated-orcid":false,"given":"Ruth H.","family":"Asch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Moisieienko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6293-1458","authenticated-orcid":false,"given":"Irina","family":"Esterlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"2296_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s13142-012-0110-2","volume":"2","author":"J Steglitz","year":"2012","unstructured":"Steglitz J, Buscemi J, Ferguson MJ. The future of pain research, education, and treatment: a summary of the IOM report \u201cRelieving pain in America: a blueprint for transforming prevention, care, education, and research\u201d. Transl Behav Med. 2012;2:6\u20138.","journal-title":"Transl Behav Med"},{"key":"2296_CR2","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","volume":"397","author":"SP Cohen","year":"2021","unstructured":"Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397:2082\u201397.","journal-title":"Lancet"},{"key":"2296_CR3","first-page":"21","volume":"88","author":"JN Katz","year":"2006","unstructured":"Katz JN. Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. JBone Jt SurgAm. 2006;88:21\u201324.","journal-title":"JBone Jt SurgAm"},{"key":"2296_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/papr.13220","volume":"23","author":"PM Mullins","year":"2023","unstructured":"Mullins PM, Yong RJ, Bhattacharyya N. Associations between chronic pain, anxiety, and depression among adults in the United States. Pain Pract. 2023;23:589\u201394.","journal-title":"Pain Pract"},{"key":"2296_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jpsychires.2009.10.013","volume":"44","author":"MM Ohayon","year":"2010","unstructured":"Ohayon MM, Schatzberg AF. Chronic pain and major depressive disorder in the general population. J Psychiatr Res. 2010;44:454\u201361.","journal-title":"J Psychiatr Res"},{"key":"2296_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/acps.12325","volume":"131","author":"B Stubbs","year":"2015","unstructured":"Stubbs B, Eggermont L, Mitchell A, De Hert M, Correll C, Soundy A, et al. The prevalence of pain in bipolar disorder: a systematic review and large-scale meta-analysis. Acta Psychiatr Scandinavica. 2015;131:75\u201388.","journal-title":"Acta Psychiatr Scandinavica"},{"key":"2296_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.7326\/0003-4819-146-2-200701160-00006","volume":"146","author":"BA Martell","year":"2007","unstructured":"Martell BA, O\u2019Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146:116\u201327.","journal-title":"Ann Intern Med"},{"key":"2296_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1533-2500.2012.00532.x","volume":"12","author":"M Gore","year":"2012","unstructured":"Gore M, Tai KS, Sadosky A, Leslie D, Stacey BR. Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings. Pain Pr. 2012;12:550\u201360.","journal-title":"Pain Pr"},{"key":"2296_CR9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra1507771","volume":"374","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, McLellan AT. Opioid Abuse in Chronic Pain\u2013Misconceptions and Mitigation Strategies. N Engl J Med. 2016;374:1253\u201363.","journal-title":"N Engl J Med"},{"key":"2296_CR10","doi-asserted-by":"publisher","first-page":"g6380","DOI":"10.1136\/bmj.g6380","volume":"350","author":"RA Deyo","year":"2015","unstructured":"Deyo RA, Von Korff M, Duhrkoop D. Opioids for low back pain. BMJ. 2015;350:g6380.","journal-title":"BMJ"},{"key":"2296_CR11","first-page":"27252","volume":"14","author":"A Baldini","year":"2012","unstructured":"Baldini A, Von Korff M, Lin EH. A review of potential adverse effects of long-term opioid therapy: a practitioner\u2019s guide. Prim care companion CNS Disord. 2012;14:27252.","journal-title":"Prim care companion CNS Disord"},{"key":"2296_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00213-002-1287-8","volume":"165","author":"E Kozela","year":"2003","unstructured":"Kozela E, Pilc A, Popik P. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacol (Berl). 2003;165:245\u201351.","journal-title":"Psychopharmacol (Berl)"},{"key":"2296_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejphar.2014.09.008","volume":"743","author":"B Smeester","year":"2014","unstructured":"Smeester B, Lunzer M, Akg\u00fcn E, Beitz A, Portoghese P. Targeting putative mu opioid\/metabotropic glutamate receptor-5 heteromers produces potent antinociception in a chronic murine bone cancer model. Eur J Pharm. 2014;743:48\u201352.","journal-title":"Eur J Pharm"},{"key":"2296_CR14","first-page":"1","volume":"40","author":"K Walker","year":"2001","unstructured":"Walker K, Bowes M, Panesar M, Davis A, Gentry C, Kesingland A, et al. Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I Selective blockade mGlu5 receptors models acute, persistent chronic pain Neuropharmacol. 2001;40:1\u20139.","journal-title":"I Selective blockade mGlu5 receptors models acute, persistent chronic pain Neuropharmacol"},{"key":"2296_CR15","doi-asserted-by":"publisher","first-page":"e103524","DOI":"10.1371\/journal.pone.0103524","volume":"9","author":"N Lax","year":"2014","unstructured":"Lax N, George D, Ignatz C, Kolber B. The mGluR5 antagonist fenobam induces analgesic conditioned place preference in mice with spared nerve injury. PLoS One. 2014;9:e103524.","journal-title":"PLoS One"},{"key":"2296_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s44158-025-00228-z","volume":"5","author":"G Mascio","year":"2025","unstructured":"Mascio G, Nicoletti F, Battaglia G, Notartomaso S. A type-5 metabotropic glutamate receptor-perineuronal net axis shapes the function of cortical GABAergic interneurons in chronic pain. J Anesthesia, Analgesia Crit Care. 2025;5:10.","journal-title":"J Anesthesia, Analgesia Crit Care"},{"key":"2296_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00001756-199412300-00053","volume":"6","author":"Z Vidny\u00e1nszky","year":"1994","unstructured":"Vidny\u00e1nszky Z, H\u00e1mori J, N\u00e9gyessy L, R\u00fcegg D, Kn\u00f6pfel T, Kuhn R, et al. Cellular and subcellular localization of the mGluR5a metabotropic glutamate receptor in rat spinal cord. Neuroreport. 1994;6:209\u201313.","journal-title":"Neuroreport"},{"key":"2296_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/cne.903550310","volume":"355","author":"C Romano","year":"1995","unstructured":"Romano C, Sesma M, McDonald C, O\u2019Malley K, AVd Pol, Olney J. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol. 1995;355:455\u201369.","journal-title":"J Comp Neurol"},{"key":"2296_CR19","doi-asserted-by":"crossref","unstructured":"Valerio A, Rizzonelli P, Paterlini M, Moretto G, Kn\u00f6pfel T, Kuhn R, et al. mGluR5 metabotropic glutamate receptor distribution in rat and human spinal cord: a developmental study. Neurosci Res. 1997;28:49\u201357.","DOI":"10.1016\/S0168-0102(97)01175-9"},{"key":"2296_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/(SICI)1096-9861(19990809)410:4<627::AID-CNE9>3.0.CO;2-8","volume":"410","author":"H Jia","year":"1999","unstructured":"Jia H, Rustioni A, Valtschanoff J. Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn. J Comp Neurol. 1999;410:627\u201342.","journal-title":"J Comp Neurol"},{"key":"2296_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s13311-018-0616-5","volume":"15","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, Charles A. Glutamate and Its Receptors as Therapeutic Targets for Migraine. Neurotherapeutics. 2018;15:361\u201370.","journal-title":"Neurotherapeutics"},{"key":"2296_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neuroscience.2017.02.046","volume":"349","author":"A David-Pereira","year":"2017","unstructured":"David-Pereira A, Sagalajev B, Wei H, Almeida A, Pertovaara A, Pinto-Ribeiro F. The medullary dorsal reticular nucleus as a relay for descending pronociception induced by the mGluR5 in the rat infralimbic cortex. Neuroscience. 2017;349:341\u201354.","journal-title":"Neuroscience"},{"key":"2296_CR23","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.3390\/ijms16034642","volume":"16","author":"M Ko","year":"2015","unstructured":"Ko M, Hsieh Y, Hsieh S, Tseng T. Nerve demyelination increases metabotropic glutamate receptor subtype 5 expression in peripheral painful mononeuropathy. Int J Mol Sci. 2015;16:4642\u201365.","journal-title":"Int J Mol Sci"},{"key":"2296_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10604","volume":"7","author":"K Vincent","year":"2016","unstructured":"Vincent K, Cornea V, Jong Y, Laferri\u00e8re A, Kumar N, Mickeviciute A, et al. Intracellular mGluR5 plays a critical role in neuropathic pain. Nat Commun. 2016;7:10604.","journal-title":"Nat Commun"},{"key":"2296_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fpsyt.2013.00039","volume":"4","author":"I Obara","year":"2013","unstructured":"Obara I, Goulding S, Gould A, Lominac K, Hu J, Zhang P, et al. Homers at the Interface between Reward and Pain. Front Psychiatry. 2013;4:39.","journal-title":"Front Psychiatry"},{"key":"2296_CR26","doi-asserted-by":"publisher","first-page":"8203","DOI":"10.1523\/JNEUROSCI.1216-10.2010","volume":"30","author":"B Kolber","year":"2010","unstructured":"Kolber B, Montana M, Carrasquillo Y, Xu J, Heinemann S, Muglia L, et al. Activation of metabotropic glutamate receptor 5 in the amygdala modulates pain-like behavior. J Neurosci. 2010;30:8203\u201313.","journal-title":"J Neurosci"},{"key":"2296_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0304-3959(96)03212-5","volume":"68","author":"K Fisher","year":"1996","unstructured":"Fisher K, Coderre T. The contribution of metabotropic glutamate receptors (mGluRs) to formalin-induced nociception. Pain. 1996;68:255\u201363.","journal-title":"Pain"},{"key":"2296_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0304-3940(03)00259-3","volume":"342","author":"M Sotgiu","year":"2003","unstructured":"Sotgiu M, Bellomi P, Biella G. The mGluR5 selective antagonist 6-methyl-2-(phenylethynyl)-pyridine reduces the spinal neuron pain-related activity in mononeuropathic rats. Neurosci Lett. 2003;342:85\u20138.","journal-title":"Neurosci Lett"},{"key":"2296_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1124\/jpet.114.222463","volume":"353","author":"L Lindemann","year":"2015","unstructured":"Lindemann L, Porter R, Scharf S, Kuennecke B, Bruns A, Kienlin MV, et al. Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression. J Pharm Exp Ther. 2015;353:213\u201333.","journal-title":"J Pharm Exp Ther"},{"key":"2296_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09991-8","volume":"7","author":"G Chung","year":"2017","unstructured":"Chung G, Kim CY, Yun Y-C, Yoon SH, Kim M-H, Kim YK, et al. Upregulation of prefrontal metabotropic glutamate receptor 5 mediates neuropathic pain and negative mood symptoms after spinal nerve injury in rats. Sci Rep. 2017;7:9743.","journal-title":"Sci Rep"},{"key":"2296_CR31","doi-asserted-by":"crossref","unstructured":"Ko H, Oh S, Zhuo M, Kaang B. Reduced acute nociception and chronic pain in Shank2\u2212\/\u2212 mice. Mol Pain. 2016;12,1744806916647056.","DOI":"10.1177\/1744806916647056"},{"key":"2296_CR32","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s00726-016-2205-4","volume":"48","author":"E Palazzo","year":"2016","unstructured":"Palazzo E, Luongo L, Guida F, Marabese I, Romano R, Iannotta M, et al. D-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice. Amino Acids. 2016;48:1553\u201367.","journal-title":"Amino Acids"},{"key":"2296_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neulet.2005.06.007","volume":"386","author":"G Miletic","year":"2005","unstructured":"Miletic G, Miyabe T, Gebhardt K, Miletic V. Increased levels of Homer1b\/c and Shank1a in the post-synaptic density of spinal dorsal horn neurons are associated with neuropathic pain in rats. Neurosci Lett. 2005;386:189\u201393.","journal-title":"Neurosci Lett"},{"key":"2296_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neulet.2013.11.049","volume":"559","author":"Y Yao","year":"2014","unstructured":"Yao Y, Zhang Y, Yang Y, Guo S, Jiang Z, Zhao Z. Spinal synaptic scaffolding protein Homer 1b\/c regulates CREB phosphorylation and c-fos activation induced by inflammatory pain in rats. Neurosci Lett. 2014;559:88\u201393.","journal-title":"Neurosci Lett"},{"key":"2296_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.pain.2010.02.001","volume":"149","author":"G Miletic","year":"2010","unstructured":"Miletic G, Dumitrascu C, Honstad C, Micic D, Miletic V. Loose ligation of the rat sciatic nerve elicits early accumulation of Shank1 protein in the post-synaptic density of spinal dorsal horn neurons. Pain. 2010;149:152\u20139.","journal-title":"Pain"},{"key":"2296_CR36","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1471-4159.2009.06437.x","volume":"112","author":"JQ Li","year":"2010","unstructured":"Li JQ, Chen SR, Chen H, Cai YQ, Pan HL. Regulation of increased glutamatergic input to spinal dorsal horn neurons by mGluR5 in diabetic neuropathic pain. J Neurochem. 2010;112:162\u201372.","journal-title":"J Neurochem"},{"key":"2296_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/j.pain.0000000000001695","volume":"161","author":"LF Cavallone","year":"2020","unstructured":"Cavallone LF, Montana MC, Frey K, Kallogjeri D, Wages JM, Rodebaugh TL, et al. The metabotropic glutamate receptor 5 negative allosteric modulator fenobam: pharmacokinetics, side effects, and analgesic effects in healthy human subjects. Pain. 2020;161:135\u201346.","journal-title":"Pain"},{"key":"2296_CR38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2174\/1570159X23666241011163035","volume":"23","author":"C Manengu","year":"2025","unstructured":"Manengu C, Zhu C-H, Zhang G-D, Tian M-M, Lan X-B, Tao L-J, et al. Metabotropic Glutamate Receptor 5: A Potential Target for Neuropathic Pain Treatment. Curr Neuropharmacol. 2025;23:276\u201394.","journal-title":"Curr Neuropharmacol"},{"key":"2296_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.biopsych.2014.06.024","volume":"77","author":"C DeLorenzo","year":"2015","unstructured":"DeLorenzo C, DellaGioia N, Bloch M, Sanacora G, Nabulsi N, Abdallah C, et al. In Vivo Ketamine-Induced Changes in [11C]ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5. Biol Psychiatry. 2015;77:266\u201375.","journal-title":"Biol Psychiatry"},{"key":"2296_CR40","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/mp.2017.58","volume":"23","author":"I Esterlis","year":"2018","unstructured":"Esterlis I, DellaGioia N, Pietrzak R, Matuskey D, Nabulsi N, Abdallah C, et al. Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression. Mol Psych. 2018;23:824\u201332.","journal-title":"Mol Psych"},{"key":"2296_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/fcp.12316","volume":"32","author":"G Pickering","year":"2018","unstructured":"Pickering G, Morel V. Memantine for the treatment of general neuropathic pain: a narrative review. Fundam Clin Pharm. 2018;32:4\u201313.","journal-title":"Fundam Clin Pharm"},{"key":"2296_CR42","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/cns.12314","volume":"20","author":"N Fayed","year":"2014","unstructured":"Fayed N, Olivan-Bl\u00e1zquez B, Herrera-Mercadal P, Puebla-Guedea M, P\u00e9rez-Yus M, Andr\u00e9s E, et al. Changes in metabolites after treatment with memantine in fibromyalgia. A double-blind randomized controlled trial with magnetic resonance spectroscopy with a 6-month follow-up. CNS Neurosci Ther. 2014;20:999\u20131007.","journal-title":"CNS Neurosci Ther"},{"key":"2296_CR43","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.neuron.2022.03.030","volume":"110","author":"M-M Zhang","year":"2022","unstructured":"Zhang M-M, Geng A-Q, Chen K, Wang J, Wang P, Qiu X-T, et al. Glutamatergic synapses from the insular cortex to the basolateral amygdala encode observational pain. Neuron. 2022;110:1993\u20132008.e6.","journal-title":"Neuron"},{"key":"2296_CR44","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41593-023-01519-w","volume":"27","author":"Q Song","year":"2024","unstructured":"Song Q, Wei A, Xu H, Gu Y, Jiang Y, Dong N, et al. An ACC\u2013VTA\u2013ACC positive-feedback loop mediates the persistence of neuropathic pain and emotional consequences. Nat Neurosci. 2024;27:272\u201385.","journal-title":"Nat Neurosci"},{"key":"2296_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj7360","volume":"13","author":"N Mercer Lindsay","year":"2021","unstructured":"Mercer Lindsay N, Chen C, Gilam G, Mackey S, Scherrer G. Brain circuits for pain and its treatment. Sci Transl Med. 2021;13:eabj7360.","journal-title":"Sci Transl Med"},{"key":"2296_CR46","unstructured":"First M, Williams J, Karg R, Spitzer R. Structured clinical interview for DSM-5 disorders, clinician version (SCID-5-CV). Arlington, VA: American Psychiatric Association. 2015."},{"key":"2296_CR47","first-page":"143","volume":"20","author":"CS Cleeland","year":"1991","unstructured":"Cleeland CS, Ryan K. The brief pain inventory. Pain Res Group. 1991;20:143\u20137.","journal-title":"Pain Res Group"},{"key":"2296_CR48","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J psychiatry. 1979;134:382\u201389.","journal-title":"Br J psychiatry"},{"key":"2296_CR49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1037\/0882-7974.12.2.277","volume":"12","author":"PM Lewinsohn","year":"1997","unstructured":"Lewinsohn PM, Seeley JR, Roberts RE, Allen NB. Center for Epidemiological Studies-Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging. 1997;12:277\u201387.","journal-title":"Psychol Aging"},{"key":"2296_CR50","doi-asserted-by":"crossref","unstructured":"Beck AT, Steer RA, Brown GK. Beck Depression Inventory-II (BDI-II). San Antonio, TX: Psychological Corporation. 1996.","DOI":"10.1037\/t00742-000"},{"key":"2296_CR51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol, Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"2296_CR52","doi-asserted-by":"crossref","unstructured":"Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959.","DOI":"10.1111\/j.2044-8341.1959.tb00467.x"},{"key":"2296_CR53","unstructured":"Smyth C. Vol. 25 10-10 (SLACK Incorporated Thorofare, NJ, 1999)."},{"key":"2296_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/2050-7283-1-30","volume":"1","author":"P Maruff","year":"2013","unstructured":"Maruff P, Lim YY, Darby D, Ellis KA, Pietrzak RH, Snyder PJ, et al. Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer\u2019s disease. BMC Psychol. 2013;1:30.","journal-title":"BMC Psychol"},{"key":"2296_CR55","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1007\/s00259-015-3094-6","volume":"42","author":"E Park","year":"2015","unstructured":"Park E, Sullivan JM, Planeta B, Gallezot J-D, Lim K, Lin S-F, et al. Test\u2013retest reproducibility of the metabotropic glutamate receptor 5 ligand [18F] FPEB with bolus plus constant infusion in humans. Eur J Nucl Med Mol Imaging. 2015;42:1530\u201341.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2296_CR56","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/jcbfm.2012.195","volume":"33","author":"JM Sullivan","year":"2013","unstructured":"Sullivan JM, Lim K, Labaree D, Lin S-f, McCarthy TJ, Seibyl JP, et al. Kinetic analysis of the metabotropic glutamate subtype 5 tracer [18F] FPEB in bolus and bolus-plus-constant-infusion studies in humans. J Cereb Blood Flow Metab. 2013;33:532\u201341.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2296_CR57","doi-asserted-by":"crossref","unstructured":"Carson RE, Barker W, Liow J-S, Carson JD, Barker WC, Johnson CA. Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction of the HRRT. IEEE Nucl Sci Symp Conf Rec. 2003;5:3281\u201385.","DOI":"10.1109\/NSSMIC.2003.1352597"},{"key":"2296_CR58","first-page":"449","volume":"2","author":"CG Abdallah","year":"2017","unstructured":"Abdallah CG, Hannestad J, Mason GF, Holmes SE, DellaGioia N, Sanacora G, et al. Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017;2:449\u201356.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"2296_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2019.116189","volume":"206","author":"ET Rolls","year":"2020","unstructured":"Rolls ET, Huang C-C, Lin C-P, Feng J, Joliot M. Automated anatomical labelling atlas 3. Neuroimage. 2020;206:116189.","journal-title":"Neuroimage"},{"key":"2296_CR60","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.nucmedbio.2007.07.009","volume":"34","author":"S Patel","year":"2007","unstructured":"Patel S, Hamill TG, Connolly B, Jagoda E, Li W, Gibson RE. Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F] F-PEB. Nucl Med Biol. 2007;34:1009\u201317.","journal-title":"Nucl Med Biol"},{"key":"2296_CR61","doi-asserted-by":"publisher","first-page":"112770","DOI":"10.1016\/j.physbeh.2019.112770","volume":"214","author":"CK Miller","year":"2020","unstructured":"Miller CK, Krentzel AA, Patisaul HB, Meitzen J. Metabotropic glutamate receptor subtype 5 (mGlu5) is necessary for estradiol mitigation of light-induced anxiety behavior in female rats. Physiol Behav. 2020;214:112770.","journal-title":"Physiol Behav"},{"key":"2296_CR62","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neuroscience.2007.09.064","volume":"151","author":"G Losi","year":"2008","unstructured":"Losi G, Garzon G, Puia G. Nongenomic regulation of glutamatergic neurotransmission in hippocampus by thyroid hormones. Neuroscience. 2008;151:155\u201363.","journal-title":"Neuroscience"},{"key":"2296_CR63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.arcmed.2005.05.008","volume":"37","author":"S Gulseren","year":"2006","unstructured":"Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokatlioglu B. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res. 2006;37:133\u20139.","journal-title":"Arch Med Res"},{"key":"2296_CR64","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.biopsych.2022.10.018","volume":"93","author":"SE Holmes","year":"2023","unstructured":"Holmes SE, Asch RH, Davis MT, DellaGioia N, Pashankar N, Gallezot J-D, et al. Differences in quantification of the metabotropic glutamate receptor 5 across bipolar disorder and major depressive disorder. Biol Psychiatry. 2023;93:1099\u2013107.","journal-title":"Biol Psychiatry"},{"key":"2296_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-022-00199-6","volume":"42","author":"S-i Hiraga","year":"2022","unstructured":"Hiraga S-i, Itokazu T, Nishibe M, Yamashita T. Neuroplasticity related to chronic pain and its modulation by microglia. Inflamm regeneration. 2022;42:15.","journal-title":"Inflamm regeneration"},{"key":"2296_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pain.2008.02.034","volume":"137","author":"A May","year":"2008","unstructured":"May A. Chronic pain may change the structure of the brain. PAIN\u00ae. 2008;137:7\u201315.","journal-title":"PAIN\u00ae"},{"key":"2296_CR67","doi-asserted-by":"crossref","unstructured":"Li Y. Synaptic plasticity and synchrony in the anterior cingulate cortex circuitry: a neural network approach to causality of chronic visceral pain and associated cognitive deficits. Syst Neurosci. 2018:21:219\u201345.","DOI":"10.1007\/978-3-319-94593-4_8"},{"key":"2296_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101925","volume":"23","author":"TM Hansen","year":"2019","unstructured":"Hansen TM, Muthulingam JA, Drewes AM, Olesen SS, Fr\u00f8kj\u00e6r JB. Cingulate glutamate levels associate with pain in chronic pancreatitis patients. NeuroImage: Clin. 2019;23:101925.","journal-title":"NeuroImage: Clin"},{"key":"2296_CR69","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/AJP.0000000000000474","volume":"33","author":"TL Pyke","year":"2017","unstructured":"Pyke TL, Osmotherly PG, Baines S. Measuring glutamate levels in the brains of fibromyalgia patients and a potential role for glutamate in the pathophysiology of fibromyalgia symptoms: a systematic review. Clin J Pain. 2017;33:944\u201354.","journal-title":"Clin J Pain"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02296-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02296-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02296-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T20:03:12Z","timestamp":1771963392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02296-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2296"],"URL":"https:\/\/doi.org\/10.1038\/s41386-025-02296-9","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}